Stimulant Abuser Groups to Engage in 12-Step (STAGE-12): A Multisite Trial in the National Institute on Drug Abuse Clinical Trials Network.

Journal of Substance Abuse Treatment 2012;44(1):103-114

Donovan, Dennis M. | Daley, Dennis C. | Brigham, Gregory S. | Hodgkins, Candace C. | Perl, Harold I. | Garrett, Sharon B. | Doyle, Suzanne R. | Floyd, Anthony S. | Knox, Patricia C. | Botero, Christopher | Kelly, Thomas M. | Killeen, Therese K. | Hayes, Carole | Kau'iBaumhofer, Nicole | Seamans, Cindy | Zammarelli, Lucy

This is the primary outcomes paper for CTN-0031. This study, National Drug Abuse Treatment Clinical Trials Network protocol CTN-0031, evaluated the effectiveness of an 8-week combined group plus individual 12-step facilitative intervention on stimulant drug use and 12-step meeting attendance and service. Using a multisite randomized controlled trial, with assessments at baseline, mid-treatment, end of treatment, and 3- and 6-month post-randomization follow-ups (FUs), individuals with stimulant use disorders (n=471) were randomly assigned to treatment as usual (TAU) or TAU into which the Stimulant Abuser Groups to Engage in 12-Step (STAGE-12) intervention was integrated. The STAGE-12 intervention used group sessions focused on increasing acceptance of 12-step principles, as well as individual sessions incorporating an intensive referral procedure connecting participants to 12-step volunteers. Compared with TAU, STAGE-12 participants had significantly greater odds of self-reported stimulant abstinence during the active 8-week treatment phase; however, among those who had not achieved abstinence during this period, STAGE-12 participants had more days of use. STAGE-12 participants had lower Addiction Severity Index Drug Composite scores at and a significant reduction from baseline to the 3-month FU, attended 12-step meetings on a greater number of days during the early phase of active treatment, engaged in more other types of 12-step activities throughout the active treatment phase and the entire FU period, and had more days of self-reported service at meetings from mid-treatment through the 6-month FU.

Conclusions: The present findings are mixed with respect to the impact of integrating the STAGE-12 intervention into intensive outpatient drug treatment compared with treatment as usual on stimulant drug use. However, the results more clearly indicate that individuals in STAGE-12 had higher rates of 12-step meeting attendance and were engaged in more related activities throughout both the active treatment phase and the entire 6-month follow-up period than did those in treatment as usual.

Keywords: CTN primary outcomes | Behavior therapy | Group therapy | Retention - Treatment | Stimulant use | Twelve-step programs | Twelve-Step Facilitation (TSF) | Journal of Substance Abuse Treatment (journal)

Document No: 816 ; PMID: 22657748 ; PMCID: PMC3434261

Submitted by: CTN Dissemination Librarians   (04/01/2012)

How to Get the Item

 Email CTN Library (free)

 PubMed Central (free)

 Journal subscriber access

Related Protocols

NIDA-CTN-0031 NIDA-CTN-0031

Participating Nodes

Pacific Northwest Appalachian Tri-State Florida Node Alliance Ohio Valley Pacific Region Southern Consortium Texas Western States

Pacific Northwest | Appalachian Tri-State | Florida Node Alliance | Ohio Valley | Pacific Region | Southern Consortium | Texas | Western States

Record Permalink
https://tinyurl.com/ctnlib816


-
Supported by a grant from the National Institute on Drug Abuse to the University of Washington Addictions, Drug & Alcohol Institute.
The materials on this site have neither been created nor reviewed by NIDA.

Powered by DB/Text WebPublisher, from Inmagic WebPublisher PRO